Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer
Can we close the Gap between Potential and Practice?
Recent publication
Dr Therese Lentner from the Division of Internal Medicine 1 at KL University Hospital St. Pölten is co-author of a study on the efficacy of immune checkpoint inhibitors in matastatic colorectal cancer. The study compares the efficacy of the therapy in patients who are microsatellite stable or exhibit an microsatellire instability status.The paper has been published open access in the journal "Current Oncology Reports".
Hamid, MA, Pammer, LM, Lentner, TK, Doleschal, B, Gruber, R, Kocher, F, Gasser, E, Jöbstl, A, Seeber, A & Amann, A 2024, 'Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?', Current Oncology Reports. https://doi.org/10.1007/s11912-024-01583-w
Dr. Theresa Lentner BSc
Division of Internal Medicine 1 (University Hospital St. Pölten)
